ST Pharm Co.,Ltd. (KOSDAQ: A237690)
Health Care · Pharmaceuticals · KR
₩106,700.00
-3.18% today · +15.1% 1Y
ST Pharm Co.,Ltd. (KOSDAQ: A237690) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.61B.
Over the last twelve months the share price has gained 15.1%, trading between 84.10K and 172.10K.
Tweenvest scores ST Pharm Co.,Ltd. across four factors: quality 65/100, value 63/100, growth 76/100, dividend 11/100. Its strongest factor is growth.
A237690 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.61B
- Revenue (TTM)
- $227.45M
- P/E
- 32.21
- EPS
- 3,312.63
- Dividend yield
- 0.45%
- Beta (5Y)
- 0.28
- 52-week high
- ₩172,100.00
- 52-week low
- ₩84,100.00
- Avg volume (3M)
- —
- Shares outstanding
- 20.88M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,235.16 | +0.12% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | 0.00% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.27 | -0.12% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.70 | -0.03% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.52 | -0.99% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.